Digital Diabetes Management Market Research Report Information by Type (Wearable Devices, Handheld Devices), Product & Services (Devices, Digital Diabetes Management Apps, Services), End User (Homecare, Academic & Research Institutes)- Forecast till 2032.

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

Chapter 3. Research Methodology

3.1. Introduction

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

Chapter 4. Market Dynamics

4.1. Drivers

4.2. Restraints

4.3. Opportunities

4.4. Challenges

4.5. Macroeconomic Indicators

4.6. Mega Trends & Assessment

Chapter 5. Market Factor Analysis

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.3. Investment Feasibility Analysis

5.4. Pricing Analysis

5.5. Regulatory Analysis

5.6. Reimbursement Scenario

Chapter 6. Global Digital Diabetes Management Market, by Type

6.1. Introduction

6.2. Wearable Devices

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3. Handheld Devices

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Digital Diabetes Management Market, by Product and Service

7.1. Introduction

7.2. Devices

7.2.1. Smart Glucose Meters

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.2. Smart Insulin Pens

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.3. Continuous Glucose Monitoring Systems

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.4. Smart Insulin Pumps/Closed Loop Systems & Smart Insulin Patches

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3. Data Management Software and Platforms

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4. Digital Diabetes Management Apps

7.4.1. Weight & Diet Management Apps

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4.2. Diabetes & Blood Glucose Tracking Apps

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5. Services

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Digital Diabetes Management Market, by End User

8.1. Introduction

8.2. Homecare

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3. Hospitals & Specialty Diabetes Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4. Academic & Research Institutes

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.5. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 9. Global Digital Diabetes Management Market, by Region

9.1. Introduction

9.2. Americas

9.2.1. North America

9.2.1.1. US

9.2.1.2. Canada

9.2.2. South America

9.3. Europe

9.3.1. Western Europe

9.3.1.1. Germany

9.3.1.2. France

9.3.1.3. Italy

9.3.1.4. Spain

9.3.1.5. UK

9.3.1.6. Rest of Western Europe

9.3.2. Eastern Europe

9.4. Asia-Pacific

9.4.1. Japan

9.4.2. China

9.4.3. India

9.4.4. Australia

9.4.5. South Korea

9.4.6. Rest of Asia-Pacific

9.5. Middle East & Africa

9.5.1. Middle East

9.5.2. Africa

Chapter 10. Company Landscape

10.1. Introduction

10.2. Market Share Analysis

10.3. Key Developments & Strategies

Chapter 11. Company Profiles

11.1. Abbott Laboratories

11.1.1. Company Overview

11.1.2. Product Overview

11.1.3. Financial Overview

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Agamatrix, Inc.

11.2.1. Company Overview

11.2.2. Product Overview

11.2.3. Financial Overview

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. Ascensia Diabetes Care Holdings Ag.

11.3.1. Company Overview

11.3.2. Product Overview

11.3.3. Financial Overview

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. B. Braun Melsungen AG

11.4.1. Company Overview

11.4.2. Product Overview

11.4.3. Financial Overview

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Dariohealth Corporation

11.5.1. Company Overview

11.5.2. Product Overview

11.5.3. Financial Overview

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. Dexcom, Inc.

11.6.1. Company Overview

11.6.2. Product Overview

11.6.3. Financial Overview

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. F. Hoffmann-La Roche

11.7.1. Company Overview

11.7.2. Product Overview

11.7.3. Financial Overview

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. Glooko, Inc.

11.8.1. Company Overview

11.8.2. Product Overview

11.8.3. Financial Overview

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. Insulet Corporation

11.9.1. Company Overview

11.9.2. Product Overview

11.9.3. Financial Overview

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. Lifescan, Inc. (A Subsidiary of Johnson & Johnson)

11.10.1. Company Overview

11.10.2. Product Overview

11.10.3. Financial Overview

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

11.11. Medtronic PLC

11.11.1. Company Overview

11.11.2. Product Overview

11.11.3. Financial Overview

11.11.4. Key Developments

11.11.5. SWOT Analysis

11.11.6. Key Strategies

11.12. Tandem Diabetes Care, Inc.

11.12.1. Company Overview

11.12.2. Product Overview

11.12.3. Financial Overview

11.12.4. Key Developments

11.12.5. SWOT Analysis

11.12.6. Key Strategies

11.13. Tidepool

11.13.1. Company Overview

11.13.2. Product Overview

11.13.3. Financial Overview

11.13.4. Key Developments

11.13.5. SWOT Analysis

11.13.6. Key Strategies

11.14. Others

Chapter 12. MRFR Conclusion

12.1. Key Findings

12.1.1. From CEO’s Viewpoint

12.1.2. Unmet Needs of the Market

12.2. Key Companies to Watch

12.3. Predictions for the Digital Diabetes Management Industry

Chapter 13. Appendix

LIST OF TABLES

Table 1. Global Digital Diabetes Management Market Synopsis, 2020-2027

Table 2. Global Digital Diabetes Management Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3. Global Digital Diabetes Management Market, by Region, 2020-2027 (USD Million)

Table 4. Global Digital Diabetes Management Market, by Type, 2020-2027 (USD Million)

Table 5. Global Digital Diabetes Management Market, by Product & Services, 2020-2027 (USD Million)

Table 6. Global Digital Diabetes Management Market, by End User, 2020-2027 (USD Million)

Table 7. North America: Digital Diabetes Management Market, by Type, 2020-2027 (USD Million)

Table 8. North America: Digital Diabetes Management Market, by Product & Services, 2020-2027 (USD Million)

Table 9. North America: Digital Diabetes Management Market, by End User, 2020-2027 (USD Million)

Table 10. US: Digital Diabetes Management Market, by Type, 2020-2027 (USD Million)

Table 11. US: Digital Diabetes Management Market, by Product & Services, 2020-2027 (USD Million)

Table 12. US: Digital Diabetes Management Market, by End User, 2020-2027 (USD Million)

Table 13. Canada: Digital Diabetes Management Market, by Type, 2020-2027 (USD Million)

Table 14. Canada: Digital Diabetes Management Market, by Product & Services, 2020-2027 (USD Million)

Table 15. Canada: Digital Diabetes Management Market, by End User, 2020-2027 (USD Million)

Table 16. South America: Digital Diabetes Management Market, by Type, 2020-2027 (USD Million)

Table 17. South America: Digital Diabetes Management Market, by Product & Services, 2020-2027 (USD Million)

Table 18. South America: Digital Diabetes Management Market, by End User, 2020-2027 (USD Million)

Table 19. Europe: Digital Diabetes Management Market, by Type, 2020-2027 (USD Million)

Table 20. Europe: Digital Diabetes Management Market, by Product & Services, 2020-2027 (USD Million)

Table 21. Europe: Digital Diabetes Management Market, by End User, 2020-2027 (USD Million)

Table 22. Western Europe: Digital Diabetes Management Market, by Type, 2020-2027 (USD Million)

Table 23. Western Europe: Digital Diabetes Management Market, by Product & Services, 2020-2027 (USD Million)

Table 24. Western Europe: Digital Diabetes Management Market, by End User, 2020-2027 (USD Million)

Table 25. Eastern Europe: Digital Diabetes Management Market, by Type, 2020-2027 (USD Million)

Table 26. Eastern Europe: Digital Diabetes Management Market, by Product & Services, 2020-2027 (USD Million)

Table 27. Eastern Europe: Digital Diabetes Management Market, by End User, 2020-2027 (USD Million)

Table 28. Asia-Pacific: Digital Diabetes Management Market, by Type, 2020-2027 (USD Million)

Table 29. Asia-Pacific: Digital Diabetes Management Market, by Product & Services, 2020-2027 (USD Million)

Table 30. Asia-Pacific: Digital Diabetes Management Market, by End User, 2020-2027 (USD Million)

Table 31. Middle East & Africa: Digital Diabetes Management Market, by Type, 2020-2027 (USD Million)

Table 32. Middle East & Africa: Digital Diabetes Management Market, by Product & Services, 2020-2027 (USD Million)

Table 33. Middle East & Africa: Digital Diabetes Management Market, by End User, 2020-2027 (USD Million)

LIST OF FIGURES

Figure 1. Research Process

Figure 2. Segmentation for Global Digital Diabetes Management Market

Figure 3. Segmentation Market Dynamics for Global Digital Diabetes Management Market

Figure 4. Global Digital Diabetes Management Market Share, by Type, 2020

Figure 5. Global Digital Diabetes Management Market Share, by Product & Services, 2020

Figure 6. Global Digital Diabetes Management Market Share, by End User, 2020

Figure 7. Global Digital Diabetes Management Market Share, by Region, 2020

Figure 8. North America: Digital Diabetes Management Market Share, by Country, 2020

Figure 9. Europe: Digital Diabetes Management Market Share, by Country, 2020

Figure 10. Asia-Pacific: Digital Diabetes Management Market Share, by Country, 2020

Figure 11. Middle East & Africa: Digital Diabetes Management Market Share, by Country, 2020

Figure 12. Global Digital Diabetes Management Market: Company Share Analysis, 2020 (%)

Figure 13. Abbott Laboratories: Key Financials

Figure 14. Abbott Laboratories: Segmental Revenue

Figure 15. Abbott Laboratories: Geographical Revenue

Figure 16. Agamatrix, Inc.: Key Financials

Figure 17. Agamatrix, Inc.: Segmental Revenue

Figure 18. Agamatrix, Inc.: Geographical Revenue

Figure 19. Ascensia Diabetes Care Holdings Ag.: Key Financials

Figure 20. Ascensia Diabetes Care Holdings Ag.: Segmental Revenue

Figure 21. Ascensia Diabetes Care Holdings Ag.: Geographical Revenue

Figure 22. B. Braun Melsungen AG: Key Financials

Figure 23. B. Braun Melsungen AG: Segmental Revenue

Figure 24. B. Braun Melsungen AG: Geographical Revenue

Figure 25. Dariohealth Corporation: Key Financials

Figure 26. Dariohealth Corporation: Segmental Revenue

Figure 27. Dariohealth Corporation: Geographical Revenue

Figure 28. Dexcom, Inc.: Key Financials

Figure 29. Dexcom, Inc.: Segmental Revenue

Figure 30. Dexcom, Inc.: Geographical Revenue

Figure 31. F. Hoffmann-La Roche: Key Financials

Figure 32. F. Hoffmann-La Roche: Segmental Revenue

Figure 33. F. Hoffmann-La Roche: Geographical Revenue

Figure 34. Glooko, Inc.: Key Financials

Figure 35. Glooko, Inc.: Segmental Revenue

Figure 36. Glooko, Inc.: Geographical Revenue

Figure 37. Insulet Corporation: Key Financials

Figure 38. Insulet Corporation: Segmental Revenue

Figure 39. Insulet Corporation: Geographical Revenue

Figure 40. Lifescan, Inc.: Key Financials

Figure 41. Lifescan, Inc.: Segmental Revenue

Figure 42. Lifescan, Inc.: Geographical Revenue

Figure 43. Medtronic PLC: Key Financials

Figure 44. Medtronic PLC: Segmental Revenue

Figure 45. Medtronic PLC: Geographical Revenue

Figure 46. Tandem Diabetes Care, Inc.: Key Financials

Figure 47. Tandem Diabetes Care, Inc.: Segmental Revenue

Figure 48. Tandem Diabetes Care, Inc.: Geographical Revenue

Figure 49. Tidepool: Key Financials

Figure 50. Tidepool: Segmental Revenue

Figure 51. Tidepool: Geographical Revenue